Welcome to LookChem.com Sign In|Join Free
  • or
1-[4-(dimethylamino)phenyl]-3-(4-nitrophenyl)prop-2-en-1-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1234-17-9

Post Buying Request

1234-17-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1234-17-9 Usage

Physical state

Yellow solid

Usage

Organic synthesis and building block for pharmaceuticals and organic compounds

Optical property

Exhibits yellow fluorescence under UV light

Potential applications

Optoelectronic materials

Medicinal properties

Anti-inflammatory and antioxidant activities

Researched for

Treatment of various diseases and conditions

Versatility

Potential applications in various industries and scientific fields

Check Digit Verification of cas no

The CAS Registry Mumber 1234-17-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,2,3 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1234-17:
(6*1)+(5*2)+(4*3)+(3*4)+(2*1)+(1*7)=49
49 % 10 = 9
So 1234-17-9 is a valid CAS Registry Number.

1234-17-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (E)-1-[4-(dimethylamino)phenyl]-3-(4-nitrophenyl)prop-2-en-1-one

1.2 Other means of identification

Product number -
Other names 4-nitro-4'-dimethylaminochalcone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1234-17-9 SDS

1234-17-9Relevant academic research and scientific papers

A chalcone-based fluorescent responsive probe for selective detection of nitroreductase activity in bacteria

Wangngae, Sirilak,Pewklang, Thitima,Chansaenpak, Kantapat,Ganta, Phongsakorn,Worakaensai, Suphanida,Siwawannapong, Kittipan,Kluaiphanngam, Surayut,Nantapong, Nawarat,Lai, Rung-Yi,Kamkaew, Anyanee

supporting information, p. 11566 - 11573 (2021/07/11)

A new chalcone-based fluorescent turn-on probe (3c) responsive to nitroreductase (NTR) activity and its application toward the detection of bacteria are presented. The probe exhibits turn-on fluorescence at 535 nm in response to NTR activity and its optic

Unexpected solvent/substitution-dependent inversion of the enantioselectivity in Michael addition reaction using chiral phase transfer catalysts

Kottala Vijaya, Ponmuthu,Murugesan, Sepperumal,Siva, Ayyanar

supporting information, p. 5209 - 5212 (2015/08/19)

New cinchonium salts bearing 5,5′-bis(methyl)-2,2′-bipyridine 1 group show solvent/substitution-dependent reversal of enantioselectivity. When used as chiral phase transfer catalyst in the asymmetric Michael addition of chalcones with diethylmalonate within two hours these catalysts result in high chemical yield (up to 98%) and enantiomeric excess (up to 99%) under lower concentrations of base and cold conditions.

Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones

-

, (2008/06/13)

The invention relates to the use of 1,3-bis-aromatic-prop-2-en-1-ones (chalcones), 1,3-bis-aromatic-propan-1-ones (dihydrochalcones), and 1,3-bis-aromatic-prop-2-yn-1-ones for the preparation of pharmaceutical compositions for the treatment or prophylaxis of a number of serious diseases including i) conditions relating to harmful effects of inflammatory cytokines, ii) conditions involving infection by Helicobacter species, iii) conditions involving infection by viruses, iv) neoplastic disorders, and v) conditions caused by microorganisms or parasites. The invention also relates to novel chalcones and dihydrochalcones (especially alkoxy substituted variants) having advantageous substitution patterns with respect to their effect as drug substances, and to methods of preparing them, as well as to pharmaceutical compositions comprising the novel chalcones. Moreover, the present invention relates to a method for the isolation of Leishmania fumarate reductase, QSAR methodologies for selecting potent compounds for the above-mentioned purposes.

Antileishmaniai chalcones: Statistical design, synthesis, and three- dimensional quantitative structure-activity relationship analysis

Nielsen, Simon Feldb?k,Christensen, S?ren Br?gger,Cruciani, Gabriele,Kharazmi, Arsalan,Liljefors, Tommy

, p. 4819 - 4832 (2007/10/03)

A large number of substituted chalcones have been synthesized and tested for antileishmanial and lymphocyte-suppressing activities. A subset of the chalcones was designed by using statistical methods. 3D-QSAR analyses using 67 (antileishmanial activity) and 63 (lymphocyte-suppressing activity) of the compounds for the training sets and 9 compounds as an external validation set were performed by using the GRID/GOLPE methodology. The Smart Region Definition procedure with subsequent region selection as implemented in GOLPE reduced the number of variables to approximately 1300 yielding 3D-QSAR models of high quality (lymphocyte-suppressing model, R2 = 0.90, Q2 = 0.80; antileishmanial model, R2 = 0.73, Q2 = 0.63). The coefficient plots indicate that steric interactions between the chalcones and the target are of major importance for the potencies of the compounds. A comparison of the coefficient plots for the antileishmanial effect and the lymphocyte- suppressing activity discloses significant differences which should make it possible to design chalcones having a high antileishmanial activity without suppressing the proliferation of lymphocytes.

Synthesis and Biological Activity of Some New 10-phenothiazines

Jaiswal, Neelam,Jaiswal, R. K.,Barthwal, J. P.,Kishor, K.

, p. 252 - 253 (2007/10/02)

Fourteen 10-phenothiazines (IV) have been synthesized via condensation of 10-hydrazino-acetylphenothiazine with substituted benzalacetophenones.These compounds inhibit 33-86percent in vitro activity of rat brain pyruvate oxidase and afford protection against pentylenetetrazol induced seizures in albino mice.However, their anticonvulsant properties are found to be independent of their pyruvate oxidase inhibitory activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1234-17-9